X
Search Filters
Format Format
Subjects Subjects
Subjects Subjects
X
Sort by Item Count (A-Z)
Filter by Count
index medicus (15) 15
humans (11) 11
animals (10) 10
male (8) 8
peripheral vascular disease (8) 8
rabbits (8) 8
signal-transduction pathway (8) 8
erythrocytes - metabolism (7) 7
physiology (7) 7
article (6) 6
cyclic amp - metabolism (6) 6
iloprost - pharmacology (6) 6
red blood cell (6) 6
articles (5) 5
erythrocytes (5) 5
erythrocytes - drug effects (5) 5
g-protein g (5) 5
iloprost (5) 5
adenosine triphosphate (4) 4
atp release (4) 4
camp (4) 4
cardiac & cardiovascular systems (4) 4
cardiac myocytes (4) 4
cyclic nucleotide phosphodiesterases, type 3 - metabolism (4) 4
hematology (4) 4
isoproterenol (4) 4
kinases (4) 4
oxygen - metabolism (4) 4
permeability (4) 4
phosphodiesterase inhibitors - pharmacology (4) 4
phosphodiesterases (4) 4
physiological aspects (4) 4
red-blood-cell (4) 4
research (4) 4
signal transduction - drug effects (4) 4
adenosine triphosphatase (3) 3
adenosine triphosphate - metabolism (3) 3
adenylate-cyclase (3) 3
adult (3) 3
cell biology (3) 3
cells (3) 3
cgmp (3) 3
compartmentalized phosphodiesterases (3) 3
cyclic nucleotide phosphodiesterases, type 4 - metabolism (3) 3
cyclic-nucleotide phosphodiesterase (3) 3
cytoskeleton (3) 3
endothelial cells (3) 3
endothelium (3) 3
erythrocyte (3) 3
erythrocytes - enzymology (3) 3
histamine (3) 3
induced increases (3) 3
isoproterenol - pharmacology (3) 3
macromolecular substances (3) 3
middle aged (3) 3
muscle proteins (3) 3
nitric-oxide (3) 3
pharmacology (3) 3
pharmacology & pharmacy (3) 3
smooth-muscle (3) 3
actin (2) 2
adenosine triphosphate - secretion (2) 2
adenylyl cyclase (2) 2
arterioles - metabolism (2) 2
barrier dysfunction (2) 2
bay 41-2272 (2) 2
beta-adrenergic receptors (2) 2
cardiovascular-system (2) 2
cell movement - drug effects (2) 2
cells, cultured (2) 2
cricetinae (2) 2
cross-talk (2) 2
cyclic amp - blood (2) 2
cyclic nucleotide phosphodiesterases, type 1 - metabolism (2) 2
cyclic nucleotide phosphodiesterases, type 2 - metabolism (2) 2
endothelium, vascular - metabolism (2) 2
enzyme activation - drug effects (2) 2
epoprostenol - analogs & derivatives (2) 2
erythrocyte membrane - drug effects (2) 2
erythrocyte membrane - enzymology (2) 2
erythrocytes - cytology (2) 2
female (2) 2
genetic aspects (2) 2
health aspects (2) 2
human umbilical vein endothelial cells - metabolism (2) 2
hypoxia (2) 2
light-chain kinase (2) 2
medicine, research & experimental (2) 2
mesocricetus (2) 2
muscle, skeletal - blood supply (2) 2
myosin (2) 2
naphthalenes - pharmacology (2) 2
p38 mitogen-activated protein kinases - antagonists & inhibitors (2) 2
p38 mitogen-activated protein kinases - metabolism (2) 2
phosphoric diester hydrolases - metabolism (2) 2
phosphorylation (2) 2
prostacyclin analogs (2) 2
protein kinase inhibitors - pharmacology (2) 2
protein kinases (2) 2
proteins (2) 2
more...
Language Language
Publication Date Publication Date
Click on a bar to filter by decade
Slide to change publication date range


PLoS ONE, ISSN 1932-6203, 05/2016, Volume 11, Issue 5, pp. e0155490 - e0155490
Journal Article
American Journal of Physiology - Heart and Circulatory Physiology, ISSN 0363-6135, 10/2010, Volume 299, Issue 4, pp. 1146 - 1152
Erythrocytes release ATP in response to exposure to the physiological stimulus of lowered oxygen (O2) tension as well as pharmacological activation of the... 
Red blood cell | Carbenoxolone | Iloprost | Cystic fibrosis transmembrane conductance regulator | Probenecid | probenecid | G-PROTEIN G(I) | CARDIAC & CARDIOVASCULAR SYSTEMS | PHYSIOLOGY | iloprost | MAXI-ANION CHANNEL | RABBIT ERYTHROCYTES | red blood cell | carbenoxolone | TRANSMEMBRANE CONDUCTANCE REGULATOR | ADENOSINE-TRIPHOSPHATE | VOLUME REGULATION | HEMICHANNELS | cystic fibrosis transmembrane conductance regulator | MIMETIC PEPTIDES | PERIPHERAL VASCULAR DISEASE | RED-BLOOD-CELL | SIGNAL-TRANSDUCTION PATHWAY | Connexins - antagonists & inhibitors | Nerve Tissue Proteins - antagonists & inhibitors | Receptors, Prostaglandin - drug effects | Receptors, Epoprostenol | Iloprost - pharmacology | Humans | Middle Aged | Probenecid - pharmacology | Male | Cystic Fibrosis Transmembrane Conductance Regulator - metabolism | Receptors, Prostaglandin - metabolism | Oxygen - metabolism | Connexins - metabolism | Erythrocytes - drug effects | Nerve Tissue Proteins - metabolism | Carbenoxolone - pharmacology | Epoprostenol - analogs & derivatives | Glyburide - pharmacology | Adenosine Triphosphate - metabolism | Erythrocytes - metabolism | Adult | Female | Care and treatment | Erythrocytes | Physiological aspects | Cystic fibrosis | Genetic aspects | Research | Adenosine triphosphate | Risk factors | Oxygen | T cell receptors | Kinases | Adenosine triphosphatase | Index Medicus
Journal Article
Journal Article
American Journal of Physiology - Cell Physiology, ISSN 0363-6143, 07/2015, Volume 309, Issue 1, pp. C51 - C59
Journal Article
Microcirculation (New York, N.Y. : 1994), ISSN 1073-9688, 5/2015, Volume 22, Issue 4, pp. 237 - 248
Journal Article
American Journal of Physiology - Heart and Circulatory Physiology, ISSN 0363-6135, 02/2010, Volume 298, Issue 2, pp. 587 - 593
Journal Article
American Journal of Physiology - Heart and Circulatory Physiology, ISSN 0363-6135, 05/2009, Volume 296, Issue 5, pp. 1617 - 1624
Activation of the G protein Gs results in increases in cAMP, a necessary step in the pathway for ATP release from rabbit and human erythrocytes. In all cells,... 
Red blood cell | Rolipram | Adenosine 3′, 5′-cyclic monophosphate | β-adrenergic receptors | Adenosine 5′-trisphophate | PROTEIN-KINASE-A | adenosine 5 '-trisphophate | CARDIAC & CARDIOVASCULAR SYSTEMS | PHYSIOLOGY | CYCLIC-NUCLEOTIDE PHOSPHODIESTERASES | CARDIAC MYOCYTES | rolipram | red blood cell | CROSS-TALK | adenosine 3 ', 5 '-cyclic monophosphate | beta-adrenergic receptors | STIMULATED PHOSPHODIESTERASE | THERAPEUTIC AGENTS | PERIPHERAL VASCULAR DISEASE | ATP RELEASE | SIGNAL-TRANSDUCTION PATHWAY | PROSTACYCLIN ANALOGS | 3',5'-Cyclic-AMP Phosphodiesterases - metabolism | Rabbits | Up-Regulation | Iloprost - pharmacology | Species Specificity | Humans | Cyclic Nucleotide Phosphodiesterases, Type 2 - metabolism | Adrenergic beta-Agonists - pharmacology | Phosphodiesterase Inhibitors - pharmacology | Erythrocyte Membrane - enzymology | Erythrocyte Membrane - drug effects | Erythrocytes - drug effects | Animals | Signal Transduction - drug effects | 3',5'-Cyclic-AMP Phosphodiesterases - antagonists & inhibitors | Adenosine Triphosphate - metabolism | Isoproterenol - pharmacology | Cyclic Nucleotide Phosphodiesterases, Type 3 - metabolism | Erythrocytes - enzymology | Cyclic Nucleotide Phosphodiesterases, Type 4 - metabolism | Cyclic AMP - metabolism | Proteins | Adenosine triphosphatase | Cells | Erythrocytes | Index Medicus | 5′-cyclic monophosphate | adenosine 5′-trisphophate | adenosine 3
Journal Article
American Journal of Physiology - Heart and Circulatory Physiology, ISSN 0363-6135, 08/2008, Volume 295, Issue 2, pp. 786 - 793
Journal Article
Frontiers in Pharmacology, ISSN 1663-9812, 2012, Volume 3, pp. 10 - 10
BAY 41-2272 (BAY), a stimulator of soluble guanylyl cyclase, increases cyclic nucleotides and inhibits proliferation of vascular smooth muscle cells (VSMCs).... 
Vasp | Soluble guanylyl cyclase | Bay 41-2272 | Camp | Cgmp | Phosphodiesterase | VASP | soluble guanylyl cyclase | cGMP | PHARMACOLOGY & PHARMACY | BAY 41-2272 | phosphodiesterase | cAMP | BAY-41-2272
Journal Article
Cellular Signalling, ISSN 0898-6568, 09/2016, Volume 28, Issue 9, pp. 1364 - 1379
Journal Article
Microcirculation, ISSN 1073-9688, 02/2011, Volume 18, Issue 2, pp. 128 - 135
Journal Article
Journal Article